Perimenopause accelerates facial aging through hormonal, structural, and psychosocial changes, presenting unique challenges for facial plastic surgeons.
Objectives:
This viewpoint article integrates two key perspectives: (1) psychosocial impacts and patient-centered care, contributed by Dr. Mary Claire Haver, a board-certified obstetrician-gynecologist and menopause specialist; and (2) hormonal influences and strategic interventions during perimenopause as a critical window for rejuvenation, contributed by Dr. Lindsey Pennington, who emphasizes integrated surgical and non-surgical approaches and notes a trend toward earlier interventions.
Conclusions:
By combining Dr. Haver’s insights on hormonal and emotional contexts with Dr. Pennington’s clinical observations experience, and Dr. Sabrina Fabi’s research on skin health and tissue regeneration, we provide a holistic framework for addressing perimenopausal facial aging.
Get full access to this article
View all access options for this article.
References
1.
SantoroN, EppersonCN, MathewsSB. Menopausal symptoms and their management. Endocrinol Metab Clin North Am. 2015; 44(3):497–515; doi: 10.1016/j.ecl.2015.05.001
2.
HallG, PhillipsTJ. Estrogen and skin: The effects of estrogen, menopause, and hormone replacement therapy on the skin. J Am Acad Dermatol. 2005; 53(4):555–568; doi: 10.1016/j.jaad.2004.08.039
3.
ShawRB, KatzelEB, KoltzPF, et al.Aging of the facial skeleton: Aesthetic implications and rejuvenation strategies. Plast Reconstr Surg. 2011; 127(1):374–383; doi: 10.1097/PRS.0b013e3181f95b2d
4.
Raine-FenningNJ, BrincatMP, Muscat-BaronY. Skin aging and menopause: Implications for treatment. Am J Clin Dermatol. 2003; 4(6):371–378; doi: 10.2165/00128071-200304060-00001
5.
ReusTL, BrohemCA, SchuckDC, et al.Revisiting the effects of menopause on the skin: What happens and what works for aging skin. Dermatol Ther., 2022; 35(9):e15713; doi: 10.1111/dth.15713
6.
WinesN, WillsteedE. Menopause and the skin. Australas J Dermatol. 2001; 42(3):149–158; doi: 10.1046/j.1440-0960.2001.00524.x
BottaiG, MancinaR, MuratoriM, et al.17β-estradiol protects human skin fibroblasts and keratinocytes against oxidative damage. J Eur Acad Dermatol Venereol. 2013; 27(10):1236–1243; doi: 10.1111/j.1468-3083.2012.04697.x
9.
RzepeckiAK, MuraseJE, JuranR, et al.Estrogen-deficient skin: The role of topical therapy. Int J Womens Dermatol. 2019; 5(2):85–90; doi: 10.1016/j.ijwd.2019.01.001
10.
BrincatMP, BaronYM, GaleaR. Estrogens and the skin. Climacteric. 2005; 8(2):110–123; doi: 10.1080/13697130500118100
11.
KissN, SzaboK, PolgarB, et al.Skin barrier function and wound healing in menopause. Menopause., 2024; 31(2):133–140; doi: 10.1097/GME.0000000000002301
HolmbergL, AndersonH, HABITS steering and data monitoring committees. HABITS (hormonal replacement therapy after breast cancer–is it safe?), a randomised comparison: Trial stopped. Lancet. 2004; 363(9407):453–455; doi: 10.1016/S0140-6736(04)15493-7
14.
BoardmanHM, HartleyL, EisingaA, et al.Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev. 2015; 2015(3):CD002229; doi: 10.1002/14651858.CD002229.pub4
15.
SchmidtJB, BinderM, DemschikG, et al.Treatment of skin aging with topical estrogens. Int J Dermatol. 1996; 35(9):669–674; doi: 10.1111/j.1365-4362.1996.tb03701.x
16.
LePillouer-ProstA, KerobD, NielsenM, et al.Topical estrogens in perimenopausal skin aging. J Cosmet Dermatol., 2020; 19(5):1056–1062; doi: 10.1111/jocd.13308
17.
DraelosZD. A clinical study to assess the facial anti-aging efficacy of topical estriol and estradiol. Alloy Women’s Health. 2024.
18.
ChoL, KaunitzAM, FaubionSS, et al.; ACC CVD in Women Committee. Rethinking menopausal hormone therapy: For whom, what, when, and how long? Circulation. 2023; 147(7):597–610; doi: 10.1161/CIRCULATIONAHA.122.061559
19.
CohenJL, GoldMH. A double-blind randomized pilot study evaluating the safety and efficacy of topical MEP in the facial appearance improvement of estrogen deficient females. J Drugs Dermatol., 2018; 17(11):1186–1189.
20.
KligmanAM, GroveGL, HiroseR, et al.Topical tretinoin for photoaged skin. J Am Acad Dermatol. 1986; 15(4 Pt 2):836–859; doi: 10.1016/s0190-9622(86)70242-9
21.
FitzpatrickRE, RostanEF. Topical vitamin C in aging. Clin Dermatol., 2002; 20(4):360–364; doi: 10.1016/s0738-081x(02)00264-x
22.
LinJY, SelimMA, SheaCR, et al.UV photoprotection by combination topical antioxidants vitamin C and vitamin E. J Am Acad Dermatol. 2003; 48(6):866–874; doi: 10.1067/mjd.2003.425
23.
GreenAC, WilliamsGM, LoganV, et al.Reduced risk of skin cancer and sunburn in a long-term randomized trial of daily use of sunscreen. JAMA Dermatol., 2011; 147(1):128–129; doi: 10.1001/archdermatol.2010.406
24.
LyndeCW. Moisturizers: What they are and a practical approach to product selection. Skin Therapy Lett., 2001; 6(5):3–5.
25.
JacquetR, ArndtJ, HlevcaC, et al.In vitro and in vivo effects of acetyl tetrapeptide-9 on collagen synthesis and skin firmness. J Cosmet Sci., 2012; 63(4):245–252.
26.
RobinsonLR, FitzgeraldNC, DoughtyDG, et al.Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. Int J Cosmet Sci. 2005; 27(3):155–160; doi: 10.1111/j.1467-2494.2005.00261.x
27.
ZussmanJ, CampeloC, MonteroE, et al.A comprehensive review of the strategies to reduce retinoid-induced skin irritation in topical formulation. Pharmaceutics. 2023; 15(8):2123; doi: 10.3390/pharmaceutics15082123
28.
EdgarJ. Getting Injectables Now Could Complicate A Facelift Later.Allure: New York, NY; 2024.
29.
HuthS, HuthL, MarquardtY, et al.Molecular insights into the effects of PLLA-SCA on gene expression. J Drugs Dermatol. 2024; 23(4):285–288; doi: 10.36849/JDD.7791
30.
ZubairR, IshiiL, LoyalJ, et al.SPLASH: Split-body randomized clinical trial of poly-L-lactic acid for adipogenesis and volumization of the hip dell. Dermatol Surg. 2024; 50(12):1155–1162; doi: 10.1097/DSS.0000000000004311
31.
FabiS, HamiltonT, LaTowskyB, et al.Effectiveness and safety of poly-L-lactic acid injectable implant in the correction of cheek wrinkles. J Drugs Dermatol. 2024; 23(1):1297–1305; doi: 10.36849/JDD.7791
32.
GoldbergD, GuanaA, VolkA, et al.Single-arm study for the characterization of human tissue response to injectable poly-L-lactic acid. Dermatol Surg. 2013; 39(6):915–922; doi: 10.1111/dsu.12164
33.
SteinP, VitavskaO, KindP, et al.The biological basis for poly-L-lactic acid-induced augmentation. J Dermatol Sci. 2015; 78(1):26–33; doi: 10.1016/j.jdermsci.2015.01.012
34.
OdoME, OdoLM, FariasRV, et al.Botulinum toxin for the treatment of menopausal hot flushes: A pilot study. Dermatol Surg. 2011; 37(11):1579–1583; doi: 10.1111/j.1524-4725.2011.02109.x
35.
TierneyEP, HankeCW. Ablative fractional CO2 laser resurfacing for photoaging of the hands. Dermatol Ther., 2011; 24(1):62–70; doi: 10.1111/j.1529-8019.2010.01383.x
36.
AlsterTS, NanniCA, WilliamsCM. Comparison of four carbon dioxide resurfacing lasers. Dermatol Surg. 1999; 25(3):153–158; discussion 159; doi: 10.1046/j.1524-4725.1999.08126.x
37.
ThorntonMJ. Estrogens and aging skin. Dermatoendocrinol. 2013; 5(2):264–270; doi: 10.4161/derm.23872
38.
HidalgoDA. Blepharoplasty techniques in the aging face. Plast Reconstr Surg., 2021; 147(3):645–656; doi: 10.1097/PRS.0000000000007702
